SKIN
NASDAQ
Consumer products
$1.11
USD
+$0.36 (+47.04%)
At close: Jul 7, 2026, 4:00 PM EDT
Market Cap:
$97.84M
Volume:
87.4M
Previous Close
$0.75
Day Range
$0.77 - $1.18
52 Week Range
$0.55 - $2.69
Average Volume (10 Days)
2.1M
P/E Ratio
0.00
Dividend Yield
—
The Beauty Health Co. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. The company is headquartered in Long Beach, California and currently employs 613 full-time employees. The company went IPO on 2020-02-10. The Company, anchored by Hydrafacial, a professional skincare treatment, and supported by complementary offerings including SkinStylus microneedling and HydraScalp with Keravive, combines advanced device technology, proprietary consumables, and clinical validation to deliver treatment experiences through an omnichannel network of providers worldwide. Hydrafacial specializes in the category of hydradermabrasion with its patented delivery system that cleanses, extracts and hydrates the skin with proprietary solutions and serums. The treatment extends to the scalp through its HydraScalp powered by Keravive treatment, which is designed to support the hair's natural growth. SkinStylus specializes in nano-channeling and microneedling where its products are designed to provide either a non-invasive (nano-channeling) or minimally-invasive (microneedling) skin treatment to individuals.
CEO
Mr. Pedro Malha
Headquaters
Long Beach, CALIFORNIA, US
Founded
2020
Employees
613
SkinHealth Systems announced the FDA cleared its SkinStylus microneedling device for improving periorbital wrinkles in all skin types, making it the only microneedling device approved for facial acne scars, periorbital wrinkles, and abdominal scars. The clearance comes as consumer spending on microneedling in U.S. aesthetic practices grew 33% year-over-year in 2025 to approximately $330 million.
0
0